- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Clarivate Upsizes Term Loan By $500 Mln To Redeem 2026 Notes, Extending Debt Maturity | ||
| Di | Herc Holdings Finalizes Acquisition Of H&E Rentals To Expand U.S. Market Presence | ||
| Di | Power Workers' Union Members Ratify Collective Agreement | ||
| Mo | Webus International Stock Falls 6% Despite Strategic Deal On Digital Asset Management | ||
| Mo | Colombier Acquisition Stock Gains 12% On Updated Merger Filing With GrabAGun | ||
| Mo | Ryvyl Stock Soars Nearly 78% | ||
| Mo | Blueprint Medicines Stock Surges 26% On Acquisition Deal With Sanofi | ||
| Mo | Opus Genetics Reports Positive Phase 3 Results For Night Vision Therapy, Stock Up | ||
| Mo | ASP Isotopes Announces Pricing Of Underwritten Registered Direct Offering | ||
| Mo | Freehold Royalties Appoints Shaina Morihira As CFO | ||
| Mo | NewGenIvf Plans To Invest $30 Mln In Solana | ||
| Mo | Catalyst Pharma Appoints William Andrews As CMO | ||
| Mo | Erasca Announces Clearance Of IND Application By FDA For ERAS-4001 | ||
| Mo | AngloGold Ashanti To Sell Mineração Serra Grande Mine For $76 Mln Cash; Stock Up In Pre-market | ||
| Mo | Teck Resources Announces Maintenance Shutdown Of SAG Mill, Shiploader In Chile | ||
| Mo | CAE Names Matthew Bromberg President And CEO, Calin Rovinescu Exe. Chairman | ||
| Mo | Ascendis Pharma: FDA Grants Priority Review For NDA For TransCon CNP | ||
| Mo | Dow To Sell 50% Stake In DowAksa Joint Venture To JV Partner For $125 Mln | ||
| Mo | Outlook Therapeutics Launches LYTENAVA For Patients With Wet AMD In Germany And The UK | ||
| Mo | Instil Bio Names Jamie Freedman Chief Medical Officer To Advance AXN-2510; Shares Surge | ||
| Mo | Science Applications International Corporation Q1 Profit Decreases, Misses Estimates | ||
| Mo | CareTrust REIT Buys Skilled Nursing Facilities In Pacific Northwest For Around $146 Mln | ||
| Mo | IsoEnergy Launches At-The-Market Equity Program | ||
| Mo | Why Vera Therapeutics Is Rising In Pre-market? | ||
| Mo | Theravance Biopharma To Sell Remaining Interest In Trelegy Ellipta To GSK For $225 Mln, Stock Up |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .